A targeted library of small molecules has been prepared to optimize the biological activity of BN82002, our initial lead compound, recently described as an original inhibitor of CDC25 phosphatases. Some of these compounds inhibit CDC25 in the micromolar range and therefore reinforce the interest of CDC25 as an anticancer target. (C) 2004 Elsevier Ltd. All rights reserved.
机构:
Univ Naples Federico II, Fac Farm, Dipartimento Chim Farmaceut & Tossicol, Drug Discovery Lab, I-80131 Naples, ItalyUniv Naples Federico II, Fac Farm, Dipartimento Chim Farmaceut & Tossicol, Drug Discovery Lab, I-80131 Naples, Italy